However, restoring hyperinsulinemia by chronic subcutaneous insulin infusion increased tumor glucose uptake and oxidation to levels measured in untreated HFD tumor-bearing mice, confirming that tumor glucose uptake and oxidation are dynamic and insulin-responsive (Fig. 3d, e). The gene discussed is INS; the disease is hyperinsulinism.